TORONTO, Sept. 2 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, today announced that it has entered into an agreement to sell its MDS Analytical Technologies business, a leading global supplier of drug discovery and life sciences research tools, to Danaher Corporation (NYSE: DHR) for $650 million in cash, and that it currently intends to return approximately $400 million to $450 million of the sale proceeds to its shareholders. The completion of the sale is subject to shareholder and regulatory approval, and other closing conditions.
What a "great" news to start the day. Barely 4 months into my first job, I have a chance to encounter such a situation. Initially shock at the news as it totally come out of the blue, I can only breath a sign of relief that it is not a competitor that acquire us, so there will be minimum restructuring. What will the future holds? I totally have no idea. If the shareholders meeting in October passes this deal, which highly it will as they stand to get lots of dividends back, no matter what, I will just adopt a wait and see attitude. At least, by December, the picture will become clearer... Contract or Perm, lets wait and see...
No comments:
Post a Comment